Flow chart of included PLWH. by Kathryn S. Hensley (14019217)

Baseline characteristics of HIV-negative controls and PLWH. by Kathryn S. Hensley (14019217)

Reactogenicity in PLWH. by Kathryn S. Hensley (14019217)

Severity of adverse events. by Kathryn S. Hensley (14019217)

HMGB1 expression in KO-PRP treated wound is much lower than GFP-PRP treated wound. by Jianying Zhang (256508)

Cellular immune responses against SARS-CoV-2 in subgroup participants (PLWH). by Kathryn S. Hensley (14019217)

Antibody concentration in PLWH and controls after vaccination. by Kathryn S. Hensley (14019217)

qRT-PCR indicates <i>runx1</i>, <i>cmyb</i>, and <i>cd41</i> expression is lower in PCP treated embryos. by Aleeza Namit (12295157)

Summary of the experimental design. by Nagwa Ibrahim Shehata (17319689)

“…The third and fourth groups received a single daily dose of 50 mg/kg Safr (intraperitoneal) and 1 mg/kg Cands (oral), respectively. …”

Macrophage marker CD68 expression is much higher in KO-PRP treated wound than GFP-PRP treated wound. by Jianying Zhang (256508)

“…GFP-PRP treated wound areas (<b>E, F,</b> and <b>K, L</b>) have decreased CD68 expression compared with saline treated wounds (<b>A, B,</b> and <b>G, H</b>). …”

Stem cell marker CD146 expression is much lower in KO-PRP treated wound than GFP-PRP treated wound. by Jianying Zhang (256508)

Differences and Similarities between Lanthanum and Rare-Earth Iodate Anhydrous Polymorphs: Structures, Thermal Behaviors, and Luminescent Properties by Yan Suffren (1625866)

Stem cell marker CD73 expression is much lower in KO-PRP treated wound compared to GFP-PRP treated wound. by Jianying Zhang (256508)

Tendon matrix marker collagen III expression is much lower in KO-PRP treated wound than GFP-PRP treated wound. by Jianying Zhang (256508)

Fig 6 - by Nagwa Ibrahim Shehata (17319689)

Fig 7 - by Nagwa Ibrahim Shehata (17319689)

Fig 9 - by Nagwa Ibrahim Shehata (17319689)

Only phosphorylation of LAT4 exhibits diurnal rhythmicity in jejunum of food-entrained wild type mice. by Lalita Oparija-Rogenmozere (8911535)

Percentage positive tests, tests turnaround times (24h-48h) and cumulative cases are reported from March 17, 2020 to November 28, 2020 in Toronto. by Elena Aruffo (11981366)

“…<p>The percentage positive tests decrease from May 31 to August 24, when it starts increasing, showing, however a magnitude smaller than the first wave in March. …”

Pyridoxine chlorhydrate forced degradation. by Marine Bonino (21156835)

“…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”